(254771, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254772, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254773, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254774, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254775, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254776, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254777, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254778, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254779, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254780, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254781, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254782, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254783, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254784, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254785, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254786, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254787, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254788, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254789, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254790, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254791, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254792, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254793, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254794, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254795, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254796, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254797, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254798, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254799, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254800, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254801, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254802, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254803, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254804, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254805, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254806, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254807, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254808, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254809, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254810, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254811, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254812, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254813, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254814, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254815, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254816, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254817, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254818, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254819, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254820, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254821, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254822, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254823, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254824, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254825, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254826, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254827, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254828, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254829, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254830, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254831, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254832, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254833, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254834, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254835, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254836, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254837, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254838, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254839, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254840, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254841, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254842, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254843, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254844, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254845, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254846, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254847, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254848, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254849, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254850, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254851, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254852, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254853, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254854, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254855, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254856, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254857, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254858, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254859, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254860, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254861, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254862, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254863, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254864, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254865, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254866, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254867, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254868, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254869, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254870, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254871, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254872, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254873, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254874, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254875, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254876, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254877, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254878, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254879, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254880, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254881, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254882, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254883, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254884, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254885, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254886, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254887, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254888, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254889, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254890, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254891, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254892, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254893, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254894, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254895, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254896, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254897, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254898, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254899, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254900, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254901, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254902, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254903, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254904, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254905, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254906, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254907, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254908, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254909, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254910, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254911, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254912, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254913, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254914, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254915, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254916, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254917, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254918, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254919, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254920, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254921, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254922, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254923, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254924, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254925, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254926, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254927, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254928, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254929, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254930, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254931, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254932, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254933, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254934, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254935, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254936, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254937, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254938, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254939, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254940, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254941, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254942, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254943, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254944, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254945, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254946, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254947, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254948, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254949, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254950, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254951, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254952, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254953, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254954, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254955, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254956, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254957, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254958, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254959, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254960, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254961, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254962, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254963, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254964, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254965, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254966, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254967, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254968, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254969, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254970, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254971, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254972, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254973, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254974, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254975, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254976, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254977, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254978, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254979, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254980, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254981, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254982, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254983, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254984, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254985, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254986, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254987, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254988, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254989, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254990, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254991, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254992, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254993, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254994, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254995, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254996, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(254997, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254998, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(254999, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255000, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255001, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255002, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255003, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255004, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255005, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255006, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255007, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255008, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255009, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255010, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255011, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255012, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255013, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255014, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255015, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255016, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255017, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255018, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255019, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255020, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255021, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255022, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255023, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255024, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255025, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255026, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255027, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255028, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255029, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255030, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255031, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255032, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255033, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255034, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255035, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255036, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255037, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255038, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255039, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255040, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255041, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255042, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255043, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255044, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255045, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255046, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255047, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255048, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255049, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255050, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255051, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255052, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255053, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255054, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255055, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255056, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255057, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255058, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255059, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255060, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255061, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255062, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255063, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255064, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255065, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255066, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255067, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255068, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255069, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255070, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255071, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255072, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255073, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255074, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255075, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255076, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255077, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255078, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255079, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255080, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255081, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255082, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255083, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255084, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255085, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255086, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255087, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255088, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255089, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255090, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255091, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255092, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255093, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255094, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255095, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255096, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255097, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255098, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255099, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255100, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255101, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255102, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255103, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255104, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255105, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255106, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255107, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255108, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255109, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255110, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255111, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255112, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255113, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255114, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255115, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255116, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255117, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255118, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255119, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255120, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255121, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255122, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255123, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255124, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255125, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255126, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255127, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255128, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255129, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255130, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255131, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255132, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255133, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255134, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255135, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255136, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255137, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255138, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255139, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255140, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255141, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255142, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255143, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255144, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255145, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255146, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255147, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255148, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255149, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255150, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255151, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255152, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255153, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255154, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255155, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255156, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255157, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255158, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255159, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255160, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255161, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255162, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255163, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255164, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255165, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255166, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255167, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255168, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255169, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255170, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255171, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255172, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255173, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255174, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255175, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255176, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255177, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255178, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255179, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255180, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255181, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255182, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255183, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255184, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255185, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255186, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255187, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255188, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255189, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255190, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255191, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255192, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255193, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255194, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255195, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255196, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255197, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255198, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255199, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255200, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255201, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255202, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255203, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255204, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255205, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255206, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255207, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255208, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255209, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255210, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255211, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255212, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255213, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255214, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255215, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255216, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255217, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255218, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255219, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255220, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255221, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255222, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255223, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255224, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255225, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255226, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255227, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255228, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255229, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255230, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255231, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255232, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255233, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255234, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255235, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255236, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255237, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255238, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255239, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255240, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255241, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255242, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255243, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255244, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255245, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255246, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255247, 'HP:0034091', 'Anti-platelet derived growth factor receptor', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255248, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.45714285714285713, 10.47786425096631, 2.1885796308203505, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255249, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0011470', 'increased urine creatinine level', 0.4057971014492754, 9.50911518495075, 1.9643755698440928, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(255250, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0002931', 'glutaricadicuria', 0.4714285714285714, 10.47786425096631, 2.2225131215485647, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255251, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020406', 'hyperthreoninuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255252, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020400', 'cystinuria', 0.44594594594594594, 10.47786425096631, 2.1616107616521485, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255253, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030618', 'tryptophanuria', 0.44594594594594594, 10.47786425096631, 2.1616107616521485, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255254, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.4230769230769231, 10.47786425096631, 2.1054554300000072, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255255, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030614', 'methylmalonic aciduria', 0.4782608695652174, 10.47786425096631, 2.2385603560890317, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255256, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020403', 'lysinuria', 0.4177215189873418, 10.47786425096631, 2.092087323860267, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255257, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030689', 'cystathioninuria', 0.4230769230769231, 10.47786425096631, 2.1054554300000072, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255258, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030616', 'hyperglycinuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255259, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030620', 'valinuria', 0.4177215189873418, 10.47786425096631, 2.092087323860267, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255260, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020405', 'taurinuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255261, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0011765', 'oroticaciduria', 0.5238095238095238, 10.47786425096631, 2.3427345312347057, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255262, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030612', 'organic aciduria', 0.41379310344827586, 10.430558536187952, 2.077520923453749, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(255263, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0011654', 'histidinuria', 0.44594594594594594, 10.47786425096631, 2.1616107616521485, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255264, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.4714285714285714, 10.47786425096631, 2.2225131215485647, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255265, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0013730', 'glutathionuria', 0.4125, 10.47786425096631, 2.0789706596110498, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255266, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020402', 'ornithinuria', 0.4230769230769231, 10.47786425096631, 2.1054554300000072, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255267, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.5245901639344263, 10.47786425096631, 2.344479585131225, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255268, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0030617', 'hyperglutaminuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255269, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0003311', 'aminoaciduria', 0.463768115942029, 10.47786425096631, 2.204381855025799, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255270, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0011517', 'hyperoxaluria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255271, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020404', 'prolinuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255272, 'HP:0003607', '4-hydroxyphenylacetic aciduria', 'MP:0020401', 'argininuria', 0.42857142857142855, 10.47786425096631, 2.119083115503998, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(255273, 'HP:0025416', 'Vaginal stricture', 'MP:0009077', 'abnormal cranial vagina morphology', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255274, 'HP:0025416', 'Vaginal stricture', 'MP:0004906', 'enlarged uterus', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255275, 'HP:0025416', 'Vaginal stricture', 'MP:0001144', 'vagina atresia', 0.45652173913043476, 11.78271883249473, 2.3192816329836745, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255276, 'HP:0025416', 'Vaginal stricture', 'MP:0003568', 'uterus atresia', 0.43478260869565216, 9.668547812575419, 2.050296671277155, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255277, 'HP:0025416', 'Vaginal stricture', 'MP:0001120', 'abnormal uterus morphology', 0.40476190476190477, 9.668547812575419, 1.978246655222643, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255278, 'HP:0025416', 'Vaginal stricture', 'MP:0003538', 'abnormal hymen development', 0.4186046511627907, 11.78271883249473, 2.2208784087891216, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255279, 'HP:0025416', 'Vaginal stricture', 'MP:0008978', 'abnormal vagina weight', 0.45652173913043476, 11.78271883249473, 2.3192816329836745, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255280, 'HP:0025416', 'Vaginal stricture', 'MP:0009209', 'abnormal internal female genitalia morphology', 0.4358974358974359, 9.668547812575419, 2.05292357391925, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255281, 'HP:0025416', 'Vaginal stricture', 'MP:0003531', 'abnormal vagina development', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255282, 'HP:0025416', 'Vaginal stricture', 'MP:0001142', 'abnormal vagina orifice morphology', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255283, 'HP:0025416', 'Vaginal stricture', 'MP:0011873', 'enlarged uterine horn', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255284, 'HP:0025416', 'Vaginal stricture', 'MP:0009063', 'abnormal oviduct size', 0.45454545454545453, 9.668547812575419, 2.0963765072766756, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255285, 'HP:0025416', 'Vaginal stricture', 'MP:0003618', 'uterine cervical atresia', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255286, 'HP:0025416', 'Vaginal stricture', 'MP:0001141', 'thickened vaginal epithelium', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255287, 'HP:0025416', 'Vaginal stricture', 'MP:0013399', 'endometrium fibrosis', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255288, 'HP:0025416', 'Vaginal stricture', 'MP:0008983', 'small vagina', 0.44680851063829785, 11.78271883249473, 2.2944757686270725, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255289, 'HP:0025416', 'Vaginal stricture', 'MP:0009225', 'abnormal uterine cervix size', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255290, 'HP:0025416', 'Vaginal stricture', 'MP:0003537', 'hydrometrocolpos', 0.43902439024390244, 11.78271883249473, 2.274401229082359, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255291, 'HP:0025416', 'Vaginal stricture', 'MP:0009708', 'vaginal septum', 0.44680851063829785, 11.78271883249473, 2.2944757686270725, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255292, 'HP:0025416', 'Vaginal stricture', 'MP:0004895', 'vagina atrophy', 0.42, 11.78271883249473, 2.2245767933806615, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255293, 'HP:0025416', 'Vaginal stricture', 'MP:0009065', 'abnormal oviduct weight', 0.425531914893617, 9.668547812575419, 2.028367734146279, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255294, 'HP:0025416', 'Vaginal stricture', 'MP:0013398', 'uterus fibrosis', 0.4444444444444444, 9.668547812575419, 2.072952570886423, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255295, 'HP:0025416', 'Vaginal stricture', 'MP:0004902', 'abnormal uterus size', 0.4444444444444444, 9.668547812575419, 2.072952570886423, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255296, 'HP:0025416', 'Vaginal stricture', 'MP:0008977', 'abnormal vagina size', 0.4883720930232558, 11.78271883249473, 2.3988228483424914, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255297, 'HP:0025416', 'Vaginal stricture', 'MP:0003540', 'imperforate hymen', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255298, 'HP:0025416', 'Vaginal stricture', 'MP:0008981', 'enlarged vagina', 0.44680851063829785, 11.78271883249473, 2.2944757686270725, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255299, 'HP:0025416', 'Vaginal stricture', 'MP:0003533', 'bifid vagina', 0.42857142857142855, 11.78271883249473, 2.247161908385273, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255300, 'HP:0025416', 'Vaginal stricture', 'MP:0008982', 'vagina hyperplasia', 0.42, 11.78271883249473, 2.2245767933806615, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255301, 'HP:0025416', 'Vaginal stricture', 'MP:0009068', 'enlarged oviduct', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255302, 'HP:0025416', 'Vaginal stricture', 'MP:0003571', 'uterus rupture', 0.4444444444444444, 9.668547812575419, 2.072952570886423, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255303, 'HP:0025416', 'Vaginal stricture', 'MP:0003536', 'vagina dryness', 0.4418604651162791, 11.78271883249473, 2.28173566033852, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255304, 'HP:0025416', 'Vaginal stricture', 'MP:0001140', 'abnormal vagina epithelium morphology', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255305, 'HP:0025416', 'Vaginal stricture', 'MP:0001139', 'abnormal vagina morphology', 0.45, 11.78271883249473, 2.3026557438363704, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255306, 'HP:0025416', 'Vaginal stricture', 'MP:0002637', 'small uterus', 0.40816326530612246, 9.668547812575419, 1.9865412268435685, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255307, 'HP:0025416', 'Vaginal stricture', 'MP:0003534', 'blind vagina', 0.43902439024390244, 11.78271883249473, 2.274401229082359, 'UPHENO:0076734', 'abnormal vagina morphology'),
(255308, 'HP:0025416', 'Vaginal stricture', 'MP:0003574', 'abnormal oviduct morphology', 0.4146341463414634, 9.668547812575419, 2.002226278078687, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255309, 'HP:0025416', 'Vaginal stricture', 'MP:0009070', 'small oviduct', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255310, 'HP:0025416', 'Vaginal stricture', 'MP:0004903', 'abnormal uterus weight', 0.4166666666666667, 9.668547812575419, 2.0071276961302416, 'UPHENO:0076766', 'abnormal internal female genitalia morphology'),
(255311, 'HP:0034354', 'Trichoschisis', 'MP:0000371', 'diluted coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255312, 'HP:0034354', 'Trichoschisis', 'MP:0002671', 'belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255313, 'HP:0034354', 'Trichoschisis', 'MP:0004034', 'belly blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255314, 'HP:0034354', 'Trichoschisis', 'MP:0009933', 'abnormal tail hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255315, 'HP:0034354', 'Trichoschisis', 'MP:0001197', 'oily skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(255316, 'HP:0034354', 'Trichoschisis', 'MP:0000400', 'abnormal awl hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255317, 'HP:0034354', 'Trichoschisis', 'MP:0012017', 'grizzled coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255318, 'HP:0034354', 'Trichoschisis', 'MP:0000372', 'irregular coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255319, 'HP:0034354', 'Trichoschisis', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(255320, 'HP:0034354', 'Trichoschisis', 'MP:0009002', 'premature hair regrowth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255321, 'HP:0034354', 'Trichoschisis', 'MP:0008238', 'abnormal dorsoventral coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255322, 'HP:0034354', 'Trichoschisis', 'MP:0020235', 'black belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255323, 'HP:0034354', 'Trichoschisis', 'MP:0010142', 'disorganized hair shaft', 0.4186046511627907, 9.570057949176055, 2.0015171169446777, 'UPHENO:0002768', 'abnormal strand of hair'),
(255324, 'HP:0034354', 'Trichoschisis', 'MP:0002075', 'abnormal coat/hair pigmentation', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255325, 'HP:0034354', 'Trichoschisis', 'MP:0013116', 'focal hair loss in head/neck region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255326, 'HP:0034354', 'Trichoschisis', 'MP:0009004', 'progressive hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255327, 'HP:0034354', 'Trichoschisis', 'MP:0003849', 'greasy coat', 0.4090909090909091, 9.570057949176055, 1.9786418843441866, 'UPHENO:0002768', 'abnormal strand of hair'),
(255328, 'HP:0034354', 'Trichoschisis', 'MP:0002073', 'abnormal hair growth', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(255329, 'HP:0034354', 'Trichoschisis', 'MP:0005171', 'absent coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255330, 'HP:0034354', 'Trichoschisis', 'MP:0009659', 'striated fur', 0.41025641025641024, 9.570057949176055, 1.9814584578473484, 'UPHENO:0002768', 'abnormal strand of hair'),
(255331, 'HP:0034354', 'Trichoschisis', 'MP:0012076', 'abnormal agouti pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255332, 'HP:0034354', 'Trichoschisis', 'MP:0000418', 'focal hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255333, 'HP:0034354', 'Trichoschisis', 'MP:0000370', 'head blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255334, 'HP:0034354', 'Trichoschisis', 'MP:0000405', 'abnormal auchene hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255335, 'HP:0034354', 'Trichoschisis', 'MP:0003196', 'calcified skin', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(255336, 'HP:0034354', 'Trichoschisis', 'MP:0020440', 'abnormal front foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255337, 'HP:0034354', 'Trichoschisis', 'MP:0011280', 'abnormal flank coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255338, 'HP:0034354', 'Trichoschisis', 'MP:0009928', 'abnormal pinna hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255339, 'HP:0034354', 'Trichoschisis', 'MP:0001511', 'disheveled coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(255340, 'HP:0034354', 'Trichoschisis', 'MP:0001510', 'abnormal coat appearance', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255341, 'HP:0034354', 'Trichoschisis', 'MP:0002938', 'white spotting', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255342, 'HP:0034354', 'Trichoschisis', 'MP:0000373', 'belly spot', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(255343, 'HP:0034354', 'Trichoschisis', 'MP:0008812', 'abnormal rostrocaudal coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255344, 'HP:0034354', 'Trichoschisis', 'MP:0010203', 'focal ventral hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255345, 'HP:0034354', 'Trichoschisis', 'MP:0005366', 'variegated coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(255346, 'HP:0034354', 'Trichoschisis', 'MP:0013117', 'focal hair loss in thorax region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255347, 'HP:0034354', 'Trichoschisis', 'MP:0009932', 'skin fibrosis', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(255348, 'HP:0034354', 'Trichoschisis', 'MP:0005409', 'darkened coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(255349, 'HP:0034354', 'Trichoschisis', 'MP:0010202', 'focal dorsal hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255350, 'HP:0034354', 'Trichoschisis', 'MP:0000397', 'abnormal guard hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255351, 'HP:0034354', 'Trichoschisis', 'MP:0008237', 'abnormal ventral coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255352, 'HP:0034354', 'Trichoschisis', 'MP:0005114', 'premature hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255353, 'HP:0034354', 'Trichoschisis', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4838709677419355, 9.570057949176055, 2.1518999050174754, 'UPHENO:0002768', 'abnormal strand of hair'),
(255354, 'HP:0034354', 'Trichoschisis', 'MP:0000411', 'shiny fur', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(255355, 'HP:0034354', 'Trichoschisis', 'MP:0013115', 'focal hair loss in abdominal region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255356, 'HP:0034354', 'Trichoschisis', 'MP:0030584', 'skin atrophy', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(255357, 'HP:0034354', 'Trichoschisis', 'MP:0000407', 'abnormal duvet hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255358, 'HP:0034354', 'Trichoschisis', 'MP:0002940', 'variable body spotting', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(255359, 'HP:0034354', 'Trichoschisis', 'MP:0000402', 'abnormal zigzag hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(255360, 'HP:0034354', 'Trichoschisis', 'MP:0009934', 'abnormal hind foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(255361, 'HP:0034354', 'Trichoschisis', 'MP:0001211', 'wrinkled skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(255362, 'HP:0034354', 'Trichoschisis', 'MP:0008899', 'plush coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(255363, 'HP:0034354', 'Trichoschisis', 'MP:0000426', 'ectopic hair growth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(255364, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255365, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255366, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255367, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255368, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255369, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255370, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255371, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255372, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255373, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255374, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255375, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255376, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255377, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255378, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255379, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255380, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255381, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255382, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255383, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255384, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255385, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255386, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255387, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255388, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255389, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255390, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255391, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255392, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255393, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255394, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255395, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255396, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255397, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255398, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255399, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255400, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255401, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255402, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255403, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255404, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255405, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255406, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255407, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255408, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255409, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255410, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255411, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255412, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255413, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255414, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255415, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255416, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255417, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255418, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255419, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255420, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255421, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255422, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255423, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255424, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255425, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255426, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255427, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255428, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255429, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255430, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255431, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255432, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255433, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255434, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255435, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255436, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255437, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255438, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255439, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255440, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255441, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255442, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255443, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255444, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255445, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255446, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255447, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255448, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255449, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255450, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255451, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255452, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255453, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255454, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255455, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255456, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255457, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255458, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255459, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255460, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255461, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255462, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255463, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255464, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255465, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255466, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255467, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255468, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255469, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255470, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255471, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255472, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255473, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255474, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255475, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255476, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255477, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255478, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255479, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255480, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255481, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255482, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255483, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255484, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255485, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255486, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255487, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255488, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255489, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255490, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255491, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255492, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255493, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255494, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255495, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255496, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255497, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255498, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255499, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255500, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255501, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255502, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255503, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255504, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255505, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255506, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255507, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255508, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255509, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255510, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255511, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255512, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255513, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255514, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255515, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255516, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255517, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255518, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255519, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255520, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255521, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255522, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255523, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255524, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255525, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255526, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255527, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255528, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255529, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255530, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255531, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255532, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255533, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255534, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255535, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255536, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255537, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255538, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255539, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255540, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255541, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255542, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255543, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255544, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255545, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255546, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255547, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255548, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255549, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255550, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255551, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255552, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255553, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255554, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255555, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255556, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255557, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255558, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255559, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255560, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255561, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255562, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255563, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255564, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255565, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255566, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255567, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255568, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255569, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255570, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255571, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255572, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255573, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255574, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255575, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255576, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255577, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255578, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255579, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255580, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255581, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255582, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255583, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255584, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255585, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255586, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255587, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255588, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255589, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255590, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255591, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255592, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255593, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255594, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255595, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255596, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255597, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255598, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255599, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255600, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255601, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255602, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255603, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255604, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255605, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255606, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255607, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255608, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255609, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255610, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255611, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255612, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255613, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255614, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255615, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255616, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255617, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255618, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255619, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255620, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255621, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255622, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255623, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255624, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255625, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255626, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255627, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255628, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255629, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255630, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255631, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255632, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255633, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255634, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255635, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255636, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255637, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255638, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255639, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255640, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255641, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255642, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255643, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255644, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255645, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255646, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255647, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255648, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255649, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255650, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255651, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255652, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255653, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255654, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255655, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255656, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255657, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255658, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255659, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255660, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255661, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255662, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255663, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255664, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255665, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255666, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255667, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255668, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255669, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255670, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255671, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255672, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255673, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255674, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255675, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255676, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255677, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255678, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255679, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255680, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255681, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255682, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255683, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255684, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255685, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255686, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255687, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255688, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255689, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255690, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255691, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255692, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255693, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255694, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255695, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255696, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255697, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255698, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255699, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255700, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255701, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255702, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255703, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255704, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255705, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255706, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255707, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255708, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255709, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255710, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255711, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255712, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255713, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255714, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255715, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255716, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255717, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255718, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255719, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255720, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255721, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255722, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255723, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255724, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255725, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255726, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255727, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255728, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255729, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255730, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255731, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255732, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255733, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255734, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255735, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255736, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255737, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255738, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255739, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255740, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255741, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255742, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255743, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255744, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255745, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255746, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255747, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255748, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255749, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255750, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255751, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255752, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255753, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255754, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255755, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255756, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255757, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255758, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255759, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255760, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255761, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255762, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255763, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255764, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255765, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255766, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255767, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255768, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255769, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255770, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255771, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255772, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255773, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255774, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255775, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255776, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255777, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255778, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255779, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255780, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255781, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255782, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255783, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255784, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255785, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255786, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255787, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255788, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255789, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255790, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255791, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255792, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255793, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255794, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255795, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255796, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255797, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255798, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255799, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255800, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255801, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255802, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255803, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255804, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255805, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255806, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255807, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255808, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255809, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255810, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255811, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255812, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255813, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255814, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255815, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255816, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255817, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255818, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255819, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255820, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255821, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255822, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255823, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255824, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255825, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255826, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255827, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255828, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255829, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255830, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255831, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255832, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255833, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255834, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255835, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255836, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255837, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255838, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255839, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255840, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255841, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255842, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255843, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255844, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255845, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255846, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255847, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255848, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255849, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255850, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255851, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255852, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255853, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255854, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255855, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255856, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255857, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255858, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255859, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255860, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255861, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255862, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255863, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255864, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255865, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255866, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255867, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255868, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255869, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255870, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255871, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255872, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255873, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255874, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255875, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255876, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255877, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255878, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255879, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255880, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255881, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255882, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255883, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255884, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255885, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255886, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255887, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255888, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255889, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255890, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255891, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255892, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255893, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255894, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255895, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255896, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255897, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255898, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255899, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255900, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255901, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255902, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255903, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255904, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255905, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255906, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255907, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255908, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255909, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255910, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255911, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255912, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255913, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255914, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255915, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255916, 'HP:0030783', 'Increased circulating interleukin 6 concentration', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(255917, 'HP:0012095', 'Multiple joint dislocation', 'MP:0002932', 'abnormal joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(255918, 'HP:0012095', 'Multiple joint dislocation', 'MP:0005508', 'abnormal skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(255919, 'HP:0012095', 'Multiple joint dislocation', 'MP:0030878', 'abnormal fibrous joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(255920, 'HP:0012095', 'Multiple joint dislocation', 'MP:0030804', 'abnormal synovial joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(255921, 'HP:0012095', 'Multiple joint dislocation', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(255922, 'HP:0012095', 'Multiple joint dislocation', 'MP:0003869', 'ectopic cartilage', 0.40540540540540543, 6.533898285880637, 1.6275373063205412, 'UPHENO:0049367', 'abnormal anatomical entity topology in independent continuant'),
(255923, 'HP:0012095', 'Multiple joint dislocation', 'MP:0030795', 'joint dislocation', 0.5806451612903226, 12.464189314069232, 2.6902176890766376, 'UPHENO:0086091', 'skeletal joint dislocation'),
(255924, 'HP:0012095', 'Multiple joint dislocation', 'MP:0013176', 'abnormal tail position or orientation', 0.40625, 6.533898285880637, 1.6292317756043824, 'UPHENO:0049367', 'abnormal anatomical entity topology in independent continuant'),
(255925, 'HP:0012095', 'Multiple joint dislocation', 'MP:0014167', 'ectopic bone', 0.45454545454545453, 6.533898285880637, 1.7233553801550567, 'UPHENO:0049367', 'abnormal anatomical entity topology in independent continuant'),
(255926, 'HP:0012095', 'Multiple joint dislocation', 'MP:0030818', 'abnormal girdle joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(255927, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0020841', 'abnormal supporting cell of carotid body morphology', 0.40816326530612246, 11.249595263293193, 2.1428185961574155, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(255928, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0003437', 'abnormal carotid body morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(255929, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0012729', 'abnormal common carotid artery morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(255930, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0006133', 'calcified artery', 0.43902439024390244, 8.259895016664046, 1.9042834277411493, 'UPHENO:0086797', 'abnormal artery morphology'),
(255931, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0011655', 'abnormal systemic artery morphology', 0.42105263157894735, 9.101997348968142, 1.9576567463188328, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(255932, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0020327', 'abnormal capillary branching pattern', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(255933, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0002191', 'abnormal artery morphology', 0.40540540540540543, 8.259895016664046, 1.8299196943682463, 'UPHENO:0086797', 'abnormal artery morphology'),
(255934, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0004938', 'dilated vasculature', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(255935, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0012562', 'blood vessel degeneration', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(255936, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0000265', 'blood vessel atresia', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(255937, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0010522', 'calcified aorta', 0.40425531914893614, 9.101997348968142, 1.9182103229833498, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(255938, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0006134', 'artery occlusion', 0.4186046511627907, 8.259895016664046, 1.8594704816403853, 'UPHENO:0086797', 'abnormal artery morphology'),
(255939, 'HP:0430021', 'Abnormal common carotid artery morphology', 'MP:0013982', 'inverse situs of great intrathoracic arteries', 0.41025641025641024, 9.101997348968142, 1.9323956009448564, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(255940, 'HP:0000292', 'Loss of facial adipose tissue', 'MP:0010025', 'decreased total body fat amount', 0.5116279069767442, 13.33412877350486, 2.6119173791961092, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(255941, 'HP:0000292', 'Loss of facial adipose tissue', 'MP:0001783', 'decreased white adipose tissue amount', 0.4489795918367347, 13.33412877350486, 2.446783949233498, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(255942, 'HP:0000292', 'Loss of facial adipose tissue', 'MP:0008853', 'decreased abdominal adipose tissue amount', 0.46808510638297873, 13.33412877350486, 2.4983008396649034, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(255943, 'HP:0000292', 'Loss of facial adipose tissue', 'MP:0001780', 'decreased brown adipose tissue amount', 0.4489795918367347, 13.33412877350486, 2.446783949233498, 'UPHENO:0063854', 'abnormally decreased number of adipose tissue'),
(255944, 'HP:0007456', 'Progressive reticulate hyperpigmentation', 'MP:0030051', 'increased foot pigmentation', 0.54, 12.607147267911277, 2.609187521944732, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(255945, 'HP:0007456', 'Progressive reticulate hyperpigmentation', 'MP:0030926', 'increased skin pigmentation', 0.6, 12.607147267911277, 2.7503251372786393, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(255946, 'HP:0007456', 'Progressive reticulate hyperpigmentation', 'MP:0030929', 'increased digit pigmentation', 0.46551724137931033, 12.607147267911277, 2.422569796274354, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(255947, 'HP:0007456', 'Progressive reticulate hyperpigmentation', 'MP:0011276', 'increased tail pigmentation', 0.5192307692307693, 12.607147267911277, 2.5585188632728824, 'UPHENO:0074584', 'increased pigmentation in skin of body'),
(255948, 'HP:0032595', 'Renal tubular epithelial cell detachment', 'MP:0011755', 'abnormal kidney collecting duct alpha-intercalated cell morphology', 0.4107142857142857, 9.69625474174526, 1.995592729080676, 'UPHENO:0084769', 'abnormal epithelial cell morphology in the independent continuant'),
(255949, 'HP:0032595', 'Renal tubular epithelial cell detachment', 'MP:0011756', 'abnormal kidney collecting duct beta-intercalated cell morphology', 0.4107142857142857, 9.69625474174526, 1.995592729080676, 'UPHENO:0084769', 'abnormal epithelial cell morphology in the independent continuant'),
(255950, 'HP:0032595', 'Renal tubular epithelial cell detachment', 'MP:0011754', 'abnormal kidney collecting duct intercalated cell morphology', 0.41818181818181815, 9.69625474174526, 2.0136527599010483, 'UPHENO:0084769', 'abnormal epithelial cell morphology in the independent continuant'),
(255951, 'HP:0032595', 'Renal tubular epithelial cell detachment', 'MP:0011757', 'abnormal kidney collecting duct principal cell morphology', 0.41818181818181815, 9.69625474174526, 2.0136527599010483, 'UPHENO:0084769', 'abnormal epithelial cell morphology in the independent continuant'),
(255952, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0013806', 'encephalopathy', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255953, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0002634', 'abnormal sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255954, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255955, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0003633', 'abnormal nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255956, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0003880', 'abnormal central pattern generator function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255957, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255958, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255959, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255960, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0006080', 'brain ischemia', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255961, 'HP:5200132', 'Atypical sensory examination of objects', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255962, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255963, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255964, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255965, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255966, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255967, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255968, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255969, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255970, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255971, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255972, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255973, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255974, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255975, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255976, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255977, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255978, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255979, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255980, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255981, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255982, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255983, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(255984, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255985, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255986, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255987, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255988, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255989, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255990, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255991, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255992, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255993, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255994, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255995, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255996, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255997, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255998, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(255999, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256000, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256001, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256002, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256003, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256004, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256005, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256006, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256007, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256008, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256009, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256010, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256011, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256012, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256013, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256014, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256015, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256016, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256017, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256018, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256019, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256020, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256021, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256022, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256023, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256024, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256025, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256026, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256027, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256028, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256029, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256030, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256031, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256032, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256033, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256034, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256035, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256036, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256037, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256038, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256039, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256040, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256041, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256042, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256043, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256044, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256045, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256046, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256047, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256048, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256049, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256050, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256051, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256052, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256053, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256054, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256055, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256056, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256057, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256058, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256059, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256060, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256061, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256062, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256063, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256064, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256065, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256066, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256067, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256068, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256069, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256070, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256071, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256072, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256073, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256074, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256075, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256076, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256077, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256078, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256079, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256080, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256081, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256082, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256083, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256084, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256085, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256086, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256087, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256088, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256089, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256090, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256091, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256092, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256093, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256094, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256095, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256096, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256097, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256098, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256099, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256100, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256101, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256102, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256103, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256104, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256105, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256106, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256107, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256108, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256109, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256110, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256111, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256112, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256113, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256114, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256115, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256116, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256117, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256118, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256119, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256120, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256121, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256122, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256123, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256124, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256125, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256126, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256127, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256128, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256129, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256130, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256131, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256132, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256133, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256134, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256135, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256136, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256137, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256138, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256139, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256140, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256141, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256142, 'HP:0032861', 'Focal non-convulsive status epilepticus with impairment of consciousness', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256143, 'HP:0004948', 'Vascular tortuosity', 'MP:0001614', 'abnormal blood vessel morphology', 0.4642857142857143, 6.6481113184978895, 1.756878798369351, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256144, 'HP:0004948', 'Vascular tortuosity', 'MP:0004112', 'abnormal arteriole morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256145, 'HP:0004948', 'Vascular tortuosity', 'MP:0002925', 'abnormal cardiovascular development', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256146, 'HP:0004948', 'Vascular tortuosity', 'MP:0014264', 'abnormal perivascular vein cell coverage', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256147, 'HP:0004948', 'Vascular tortuosity', 'MP:0005413', 'vascular restenosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256148, 'HP:0004948', 'Vascular tortuosity', 'MP:0000260', 'abnormal angiogenesis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256149, 'HP:0004948', 'Vascular tortuosity', 'MP:0020329', 'decreased capillary density', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256150, 'HP:0004948', 'Vascular tortuosity', 'MP:0011569', 'abnormal azygos vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256151, 'HP:0004948', 'Vascular tortuosity', 'MP:0010017', 'visceral vascular congestion', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256152, 'HP:0004948', 'Vascular tortuosity', 'MP:0003279', 'aneurysm', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256153, 'HP:0004948', 'Vascular tortuosity', 'MP:0000259', 'abnormal vascular development', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256154, 'HP:0004948', 'Vascular tortuosity', 'MP:0001619', 'abnormal vascular permeability', 0.40540540540540543, 7.347404004220494, 1.7258844975861822, 'UPHENO:0080362', 'abnormal cardiovascular system'),
(256155, 'HP:0004948', 'Vascular tortuosity', 'MP:0000486', 'abnormal pulmonary trunk morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256156, 'HP:0004948', 'Vascular tortuosity', 'MP:0000265', 'blood vessel atresia', 0.4117647058823529, 6.6481113184978895, 1.6545263980167935, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256157, 'HP:0004948', 'Vascular tortuosity', 'MP:0020373', 'abnormal blood vessel lumen formation', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256158, 'HP:0004948', 'Vascular tortuosity', 'MP:0005601', 'increased angiogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256159, 'HP:0004948', 'Vascular tortuosity', 'MP:0003227', 'abnormal vascular branching morphogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256160, 'HP:0004948', 'Vascular tortuosity', 'MP:0003228', 'abnormal sinus venosus morphology', 0.40625, 5.978701727774094, 1.5584760430973028, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256161, 'HP:0004948', 'Vascular tortuosity', 'MP:0013925', 'abnormal vascular plexus formation', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256162, 'HP:0004948', 'Vascular tortuosity', 'MP:0012562', 'blood vessel degeneration', 0.4117647058823529, 6.6481113184978895, 1.6545263980167935, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256163, 'HP:0004948', 'Vascular tortuosity', 'MP:0002725', 'abnormal vein morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256164, 'HP:0004948', 'Vascular tortuosity', 'MP:0013872', 'abnormal jugular vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256165, 'HP:0004948', 'Vascular tortuosity', 'MP:0005338', 'atherosclerotic lesions', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256166, 'HP:0004948', 'Vascular tortuosity', 'MP:0000255', 'blood vessel congestion', 0.4482758620689655, 6.6481113184978895, 1.7263220535085824, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256167, 'HP:0004948', 'Vascular tortuosity', 'MP:0013869', 'vascular diverticulum', 0.4482758620689655, 6.6481113184978895, 1.7263220535085824, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256168, 'HP:0004948', 'Vascular tortuosity', 'MP:0002191', 'abnormal artery morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256169, 'HP:0004948', 'Vascular tortuosity', 'MP:0005340', 'abnormal susceptibility to atherosclerosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256170, 'HP:0004948', 'Vascular tortuosity', 'MP:0020328', 'abnormal capillary density', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256171, 'HP:0004948', 'Vascular tortuosity', 'MP:0005412', 'vascular stenosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256172, 'HP:0004948', 'Vascular tortuosity', 'MP:0009489', 'abnormal blood vessel endothelium morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256173, 'HP:0004948', 'Vascular tortuosity', 'MP:0005602', 'decreased angiogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256174, 'HP:0004948', 'Vascular tortuosity', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256175, 'HP:0004948', 'Vascular tortuosity', 'MP:0003991', 'arteriosclerosis', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256176, 'HP:0004948', 'Vascular tortuosity', 'MP:0012253', 'abnormal intersomitic vessel morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256177, 'HP:0004948', 'Vascular tortuosity', 'MP:0009577', 'abnormal developmental vascular remodeling', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256178, 'HP:0004948', 'Vascular tortuosity', 'MP:0006083', 'abnormal blood vessel elastic tissue morphology', 0.45161290322580644, 6.6481113184978895, 1.7327356559830975, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256179, 'HP:0004948', 'Vascular tortuosity', 'MP:0003710', 'abnormal physiological neovascularization', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256180, 'HP:0004948', 'Vascular tortuosity', 'MP:0013983', 'abnormal superior mesenteric vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256181, 'HP:0004948', 'Vascular tortuosity', 'MP:0013812', 'enlarged orbital veins', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256182, 'HP:0004948', 'Vascular tortuosity', 'MP:0006136', 'varicose veins', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256183, 'HP:0004948', 'Vascular tortuosity', 'MP:0011655', 'abnormal systemic artery morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256184, 'HP:0004948', 'Vascular tortuosity', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256185, 'HP:0004948', 'Vascular tortuosity', 'MP:0005341', 'decreased susceptibility to atherosclerosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256186, 'HP:0004948', 'Vascular tortuosity', 'MP:0013863', 'abnormal paraumbilical vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256187, 'HP:0004948', 'Vascular tortuosity', 'MP:0010668', 'abnormal hepatic portal vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256188, 'HP:0004948', 'Vascular tortuosity', 'MP:0013811', 'abnormal orbital vein morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256189, 'HP:0004948', 'Vascular tortuosity', 'MP:0020330', 'increased capillary density', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256190, 'HP:0004948', 'Vascular tortuosity', 'MP:0013332', 'peliosis', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(256191, 'HP:0004948', 'Vascular tortuosity', 'MP:0003658', 'abnormal capillary morphology', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256192, 'HP:0004948', 'Vascular tortuosity', 'MP:0004125', 'abnormal venule morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(256193, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0004968', 'kidney epithelium hyperplasia', 0.40425531914893614, 8.472720947690348, 1.850714054295919, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(256194, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0002955', 'increased compensatory renal growth', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256195, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0011293', 'dilated nephron', 0.4166666666666667, 8.69825431939161, 1.9037522509717062, 'UPHENO:0076756', 'abnormal nephron morphology'),
(256196, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0003985', 'renal fibrosis', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256197, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0003197', 'nephrocalcinosis', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256198, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0011377', 'renal glomerulus fibrosis', 0.40384615384615385, 9.252530554317739, 1.9330284213392313, 'UPHENO:0086686', 'abnormal cortex of kidney morphology'),
(256199, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0002706', 'abnormal kidney size', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256200, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0011360', 'kidney cortex hypoplasia', 0.40816326530612246, 10.972941248170269, 2.1163061049539635, 'UPHENO:0019594', 'abnormal cortex of kidney morphology'),
(256201, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0009641', 'kidney degeneration', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256202, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0003881', 'abnormal nephron morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(256203, 'HP:0033296', 'Binucleated visceral epithelial cells', 'MP:0002956', 'decreased compensatory renal growth', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(256204, 'HP:0003725', 'Firm muscles', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256205, 'HP:0003725', 'Firm muscles', 'MP:0003119', 'abnormal digestive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256206, 'HP:0003725', 'Firm muscles', 'MP:0020982', 'abnormal skin adnexa development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256207, 'HP:0003725', 'Firm muscles', 'MP:0002113', 'abnormal skeleton development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256208, 'HP:0003725', 'Firm muscles', 'MP:0012260', 'encephalomeningocele', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256209, 'HP:0003725', 'Firm muscles', 'MP:0003942', 'abnormal urinary system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256210, 'HP:0003725', 'Firm muscles', 'MP:0013332', 'peliosis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256211, 'HP:0003725', 'Firm muscles', 'MP:0013119', 'abdomen swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256212, 'HP:0003725', 'Firm muscles', 'MP:0001929', 'abnormal gametogenesis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256213, 'HP:0003725', 'Firm muscles', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256214, 'HP:0003725', 'Firm muscles', 'MP:0003115', 'abnormal respiratory system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256215, 'HP:0003725', 'Firm muscles', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256216, 'HP:0003725', 'Firm muscles', 'MP:0003384', 'abnormal ventral body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256217, 'HP:0003725', 'Firm muscles', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256218, 'HP:0003725', 'Firm muscles', 'MP:0000749', 'muscle degeneration', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256219, 'HP:0003725', 'Firm muscles', 'MP:0010630', 'abnormal cardiac muscle tissue morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256220, 'HP:0003725', 'Firm muscles', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256221, 'HP:0003725', 'Firm muscles', 'MP:0013118', 'swellings', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256222, 'HP:0003725', 'Firm muscles', 'MP:0003199', 'calcified muscle', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256223, 'HP:0003725', 'Firm muscles', 'MP:0005500', 'abnormal gustatory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256224, 'HP:0003725', 'Firm muscles', 'MP:0005029', 'abnormal amnion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256225, 'HP:0003725', 'Firm muscles', 'MP:0003936', 'abnormal reproductive system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256226, 'HP:0003725', 'Firm muscles', 'MP:0002160', 'abnormal reproductive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256227, 'HP:0003725', 'Firm muscles', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256228, 'HP:0003725', 'Firm muscles', 'MP:0002925', 'abnormal cardiovascular development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256229, 'HP:0003725', 'Firm muscles', 'MP:0003939', 'abnormal myotome morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256230, 'HP:0003725', 'Firm muscles', 'MP:0030222', 'hyperostosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256231, 'HP:0003725', 'Firm muscles', 'MP:0003385', 'abnormal body wall morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256232, 'HP:0003725', 'Firm muscles', 'MP:0013120', 'urogenital swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256233, 'HP:0003725', 'Firm muscles', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256234, 'HP:0003725', 'Firm muscles', 'MP:0002210', 'abnormal sex determination', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256235, 'HP:0003725', 'Firm muscles', 'MP:0014134', 'abnormal embryo morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256236, 'HP:0003725', 'Firm muscles', 'MP:0031310', 'abnormal cyst', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256237, 'HP:0003725', 'Firm muscles', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256238, 'HP:0003725', 'Firm muscles', 'MP:0013121', 'testicular swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256239, 'HP:0003725', 'Firm muscles', 'MP:0013177', 'abnormal tail tip morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256240, 'HP:0003725', 'Firm muscles', 'MP:0010233', 'hairless tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256241, 'HP:0003725', 'Firm muscles', 'MP:0031099', 'abnormal sputum morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256242, 'HP:0003725', 'Firm muscles', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256243, 'HP:0003725', 'Firm muscles', 'MP:0009407', 'increased skeletal muscle fiber density', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256244, 'HP:0003725', 'Firm muscles', 'MP:0006279', 'abnormal limb development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256245, 'HP:0003725', 'Firm muscles', 'MP:0000462', 'abnormal digestive system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256246, 'HP:0003725', 'Firm muscles', 'MP:0012413', 'decreased muscle tumor incidence', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256247, 'HP:0003725', 'Firm muscles', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256248, 'HP:0003725', 'Firm muscles', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256249, 'HP:0003725', 'Firm muscles', 'MP:0003397', 'increased muscle weight', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256250, 'HP:0003725', 'Firm muscles', 'MP:0010478', 'intracranial aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256251, 'HP:0003725', 'Firm muscles', 'MP:0008923', 'thoracoschisis', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256252, 'HP:0003725', 'Firm muscles', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256253, 'HP:0003725', 'Firm muscles', 'MP:0003346', 'abnormal pectoral muscle morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256254, 'HP:0003725', 'Firm muscles', 'MP:0002132', 'abnormal respiratory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256255, 'HP:0003725', 'Firm muscles', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256256, 'HP:0003725', 'Firm muscles', 'MP:0000266', 'abnormal heart morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256257, 'HP:0003725', 'Firm muscles', 'MP:0003935', 'abnormal craniofacial development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256258, 'HP:0003725', 'Firm muscles', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256259, 'HP:0003725', 'Firm muscles', 'MP:0003300', 'gastrointestinal ulcer', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256260, 'HP:0003725', 'Firm muscles', 'MP:0003632', 'abnormal nervous system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256261, 'HP:0003725', 'Firm muscles', 'MP:0004817', 'abnormal skeletal muscle mass', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256262, 'HP:0003725', 'Firm muscles', 'MP:0031112', 'rhabdomyolysis', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256263, 'HP:0003725', 'Firm muscles', 'MP:0013133', 'pale limbs', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256264, 'HP:0003725', 'Firm muscles', 'MP:0000767', 'abnormal smooth muscle morphology', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256265, 'HP:0003725', 'Firm muscles', 'MP:0009419', 'skeletal muscle fibrosis', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256266, 'HP:0003725', 'Firm muscles', 'MP:0005360', 'urolithiasis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256267, 'HP:0003725', 'Firm muscles', 'MP:0004087', 'abnormal muscle fiber morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256268, 'HP:0003725', 'Firm muscles', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256269, 'HP:0003725', 'Firm muscles', 'MP:0014068', 'abnormal muscle glycogen level', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256270, 'HP:0003725', 'Firm muscles', 'MP:0012249', 'absent myotome', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256271, 'HP:0003725', 'Firm muscles', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256272, 'HP:0003725', 'Firm muscles', 'MP:0013283', 'failure of ventral body wall closure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256273, 'HP:0003725', 'Firm muscles', 'MP:0020973', 'abnormal gland development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256274, 'HP:0003725', 'Firm muscles', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256275, 'HP:0003725', 'Firm muscles', 'MP:0020981', 'abnormal immune system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256276, 'HP:0003725', 'Firm muscles', 'MP:0000685', 'abnormal immune system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256277, 'HP:0003725', 'Firm muscles', 'MP:0010352', 'gastrointestinal tract polyps', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256278, 'HP:0003725', 'Firm muscles', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256279, 'HP:0003725', 'Firm muscles', 'MP:0004818', 'increased skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256280, 'HP:0003725', 'Firm muscles', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256281, 'HP:0003725', 'Firm muscles', 'MP:0031277', 'pectus carinatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256282, 'HP:0003725', 'Firm muscles', 'MP:0010290', 'increased muscle tumor incidence', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256283, 'HP:0003725', 'Firm muscles', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256284, 'HP:0003725', 'Firm muscles', 'MP:0014062', 'nervous system inclusion bodies', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256285, 'HP:0003725', 'Firm muscles', 'MP:0005499', 'abnormal olfactory system morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256286, 'HP:0003725', 'Firm muscles', 'MP:0000736', 'delayed muscle development', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256287, 'HP:0003725', 'Firm muscles', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256288, 'HP:0003725', 'Firm muscles', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256289, 'HP:0003725', 'Firm muscles', 'MP:0000428', 'abnormal craniofacial morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256290, 'HP:0003725', 'Firm muscles', 'MP:0013124', 'mouth swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256291, 'HP:0003725', 'Firm muscles', 'MP:0013113', 'greasy tail', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256292, 'HP:0003725', 'Firm muscles', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256293, 'HP:0003725', 'Firm muscles', 'MP:0003279', 'aneurysm', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256294, 'HP:0003725', 'Firm muscles', 'MP:0003861', 'abnormal nervous system development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256295, 'HP:0003725', 'Firm muscles', 'MP:0002111', 'abnormal tail morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256296, 'HP:0003725', 'Firm muscles', 'MP:0013122', 'tail swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256297, 'HP:0003725', 'Firm muscles', 'MP:0001726', 'abnormal allantois morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256298, 'HP:0003725', 'Firm muscles', 'MP:0005503', 'abnormal tendon morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256299, 'HP:0003725', 'Firm muscles', 'MP:0011167', 'abnormal adipose tissue development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256300, 'HP:0003725', 'Firm muscles', 'MP:0004819', 'decreased skeletal muscle mass', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256301, 'HP:0003725', 'Firm muscles', 'MP:0002836', 'abnormal chorion morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256302, 'HP:0003725', 'Firm muscles', 'MP:0005508', 'abnormal skeleton morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256303, 'HP:0003725', 'Firm muscles', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256304, 'HP:0003725', 'Firm muscles', 'MP:0002108', 'abnormal muscle morphology', 0.5714285714285714, 7.206267831629091, 2.029252900049543, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256305, 'HP:0003725', 'Firm muscles', 'MP:0002109', 'abnormal limb morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256306, 'HP:0003725', 'Firm muscles', 'MP:0031377', 'ambiguous external genitalia', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256307, 'HP:0003725', 'Firm muscles', 'MP:0013123', 'head/neck swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256308, 'HP:0003725', 'Firm muscles', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256309, 'HP:0003725', 'Firm muscles', 'MP:0004233', 'abnormal muscle weight', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256310, 'HP:0003725', 'Firm muscles', 'MP:0004134', 'abnormal chest morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256311, 'HP:0003725', 'Firm muscles', 'MP:0000731', 'increased collagen deposition in the muscles', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256312, 'HP:0003725', 'Firm muscles', 'MP:0011174', 'lipodystrophy', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256313, 'HP:0003725', 'Firm muscles', 'MP:0012514', 'pectus excavatum', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256314, 'HP:0003725', 'Firm muscles', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256315, 'HP:0003725', 'Firm muscles', 'MP:0013126', 'teat swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256316, 'HP:0003725', 'Firm muscles', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256317, 'HP:0003725', 'Firm muscles', 'MP:0006281', 'abnormal tail development', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256318, 'HP:0003725', 'Firm muscles', 'MP:0000752', 'dystrophic muscle', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256319, 'HP:0003725', 'Firm muscles', 'MP:0002163', 'abnormal gland morphology', 0.45454545454545453, 2.6504988612427964, 1.0976211594424627, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256320, 'HP:0003725', 'Firm muscles', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256321, 'HP:0003725', 'Firm muscles', 'MP:0000733', 'abnormal muscle development', 0.5454545454545454, 7.206267831629091, 1.9825971715214765, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(256322, 'HP:0003725', 'Firm muscles', 'MP:0000003', 'abnormal adipose tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256323, 'HP:0003725', 'Firm muscles', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256324, 'HP:0003725', 'Firm muscles', 'MP:0013125', 'thorax swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256325, 'HP:0003725', 'Firm muscles', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256326, 'HP:0003725', 'Firm muscles', 'MP:0003795', 'abnormal bone structure', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(256327, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256328, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256329, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256330, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256331, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256332, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256333, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256334, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256335, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256336, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256337, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256338, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256339, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256340, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256341, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256342, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256343, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256344, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256345, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256346, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256347, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256348, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256349, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256350, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256351, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256352, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256353, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256354, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256355, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256356, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256357, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256358, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256359, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256360, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256361, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256362, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256363, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256364, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256365, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256366, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256367, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256368, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256369, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256370, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256371, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256372, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256373, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256374, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256375, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256376, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256377, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256378, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256379, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256380, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256381, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256382, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256383, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256384, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256385, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256386, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256387, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256388, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256389, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256390, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256391, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256392, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256393, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256394, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256395, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256396, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256397, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256398, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256399, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256400, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256401, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256402, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256403, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256404, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256405, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256406, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256407, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256408, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256409, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256410, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256411, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256412, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256413, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256414, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256415, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256416, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256417, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256418, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256419, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256420, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256421, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256422, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256423, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256424, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256425, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256426, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256427, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256428, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256429, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256430, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256431, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256432, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256433, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256434, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256435, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256436, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256437, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256438, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256439, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256440, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256441, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256442, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256443, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256444, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256445, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256446, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256447, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256448, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256449, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256450, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256451, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256452, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256453, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256454, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256455, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256456, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256457, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256458, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256459, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256460, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256461, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256462, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256463, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256464, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256465, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256466, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256467, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256468, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256469, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256470, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256471, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256472, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256473, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256474, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256475, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256476, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256477, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256478, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256479, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256480, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256481, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256482, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256483, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256484, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256485, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256486, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256487, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256488, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256489, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256490, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256491, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256492, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256493, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256494, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256495, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256496, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256497, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256498, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256499, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256500, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256501, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256502, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256503, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256504, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256505, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256506, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256507, 'HP:0032693', 'Focal cognitive seizure with neglect', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256508, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256509, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256510, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256511, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256512, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256513, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256514, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256515, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256516, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256517, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256518, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256519, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256520, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256521, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256522, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256523, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256524, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256525, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256526, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256527, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256528, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256529, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256530, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256531, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256532, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256533, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256534, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256535, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256536, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256537, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256538, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256539, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256540, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256541, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256542, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256543, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256544, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256545, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256546, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256547, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256548, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256549, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256550, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256551, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256552, 'HP:0032783', 'Focal aware autonomic seizure with piloerection', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256553, 'HP:0012889', 'Cervical endometriosis', 'MP:0009225', 'abnormal uterine cervix size', 0.40350877192982454, 13.384754846574829, 2.3239763317906608, 'UPHENO:0087947', 'abnormal uterine cervix morphology'),
(256554, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256555, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256556, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256557, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256558, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256559, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256560, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256561, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256562, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256563, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256564, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256565, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256566, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256567, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256568, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256569, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256570, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256571, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256572, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256573, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256574, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256575, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256576, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256577, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256578, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256579, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256580, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256581, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256582, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256583, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256584, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256585, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256586, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256587, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256588, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256589, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256590, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256591, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256592, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256593, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256594, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256595, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256596, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256597, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256598, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256599, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256600, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256601, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256602, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256603, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256604, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003484', 'abnormal channel response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256605, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256606, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256607, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256608, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256609, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256610, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256611, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256612, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256613, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256614, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256615, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256616, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256617, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256618, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256619, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256620, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256621, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256622, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256623, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256624, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256625, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256626, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256627, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000921', 'demyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256628, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256629, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256630, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256631, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256632, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0014256', 'decreased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256633, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256634, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256635, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256636, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256637, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256638, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256639, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256640, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256641, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256642, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256643, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256644, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256645, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256646, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256647, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256648, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256649, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256650, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256651, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256652, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256653, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256654, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256655, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256656, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256657, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256658, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256659, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256660, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256661, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256662, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256663, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256664, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256665, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256666, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256667, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256668, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256669, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256670, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256671, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003889', 'enhanced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256672, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256673, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256674, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256675, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256676, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256677, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256678, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256679, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256680, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003633', 'abnormal nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256681, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256682, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256683, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256684, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0010149', 'abnormal synaptic dopamine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256685, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(256686, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(256687, 'HP:0032718', 'Focal motor seizure with dystonia', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
